Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 49, Issue , 2014, Pages 21-29

  Liu, Dexiang ^a   Zhang, Qingrui ^a   Gu, Jianhua ^a   Wang, Xueer ^a,b   Xie, Kai ^a   Xian, Xiuying ^a   Wang, Jianmei ^a   Jiang, Hong ^a   Wang, Zhen ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LUOYANG NORMAL UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor (BDNF); Chronic unpredictable mild stress (CUMS); Cognitive deficits; Resveratrol

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RESVERATROL; RNA; NEUROPROTECTIVE AGENT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN LEVEL; CHRONIC DRUG ADMINISTRATION; CHRONIC UNPREDICTABLE MILD STRESS; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; HIPPOCAMPUS; MALE; MAZE TEST; NEUROPROTECTION; NONHUMAN; PATTERN RECOGNITION; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; TREATMENT DURATION; UPREGULATION; ANIMAL; BLOOD; COGNITION DISORDERS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; MENTAL STRESS; METABOLISM; PHOSPHORYLATION; RECOGNITION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; CORTICOSTERONE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PREFRONTAL CORTEX; RATS; RECOGNITION (PSYCHOLOGY); STILBENES; STRESS, PSYCHOLOGICAL;

EID: 84888803842     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.10.017     Document Type: Article

References (51)

1. Airaksinen E., Larsson M., Lundberg I., Forsell Y. Cognitive functions in depressive disorders: evidence from a population-based study. Psychol Med 2004, 34:83-91.
2. Albani D., Polito L., Batelli S., De Mauro S., Fracasso C., Martelli G., et al. The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J Neurochem 2009, 110:1445-1456.
3. Aleisa A.M., Alzoubi K.H., Gerges N.Z., Alkadhi K.A. Chronic psychosocial stress-induced impairment of hippocampal LTP: possible role of BDNF. Neurobiol Dis 2006, 22:453-462.
4. Alonso M., Vianna M.R., Depino A.M., Mello e Souza T., Pereira P., Szapiro G., et al. BDNF-triggered events in the rat hippocampus are required for both short- and long-term memory formation. Hippocampus 2002, 12:551-560.
5. Augustin M.A., Sanguansri L., Lockett T. Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol. Ann N Y Acad Sci 2013, 1290:107-112.
6. Bondi C.O., Rodriguez G., Gould G.G., Frazer A., Morilak D.A. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 2008, 33:320-331.
7. Chandran A., Iyo A.H., Jernigan C.S., Legutko B., Austin M.C., Karolewicz B. Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress. Prog Neuropsychopharmacol Biol Psychiatry 2013, 40:240-245.
8. Chen Y., Rex C.S., Rice C.J., Dube C.M., Gall C.M., Lynch G., et al. Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing hormone signaling. Proc Natl Acad Sci U S A 2010, 107:13123-13128.
9. Figurov A., Pozzo-Miller L.D., Olafsson P., Wang T., Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 1996, 381:706-709.
10. First M., Gil-Ad I., Taler M., Tarasenko I., Novak N., Weizman A. The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression. J Mol Neurosci 2011, 45:246-255.
11. First M., Gil-Ad I., Taler M., Tarasenko I., Novak N., Weizman A. The effects of reboxetine treatment on depression-like behavior, brain neurotrophins, and ERK expression in rats exposed to chronic mild stress. J Mol Neurosci 2013, 50:88-97.
12. Gersner R., Toth E., Isserles M., Zangen A. Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor. Biol Psychiatry 2010, 67:125-132.
13. Girbovan C., Morin L., Plamondon H. Repeated resveratrol administration confers lasting protection against neuronal damage but induces dose-related alterations of behavioral impairments after global ischemia. Behav Pharmacol 2012, 23:1-13.
14. Gronli J., Bramham C., Murison R., Kanhema T., Fiske E., Bjorvatn B., et al. Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacol Biochem Behav 2006, 85:842-849.
15. Gumuslu E., Mutlu O., Sunnetci D., Ulak G., Celikyurt I.K., Cine N., et al. The effects of tianeptine, olanzapine and fluoxetine on the cognitive behaviors of unpredictable chronic mild stress-exposed mice. Drug Res (Stuttg) 2013, 63:532-939.
16. Henningsen K., Andreasen J.T., Bouzinova E.V., Jayatissa M.N., Jensen M.S., Redrobe J.P., et al. Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic-like responses. Behav Brain Res 2009, 198:136-141.
17. Houslay M.D., Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol 2000, 58:659-668.
18. Huang T.C., Lu K.T., Wo Y.Y., Wu Y.J., Yang Y.L. Resveratrol protects rats from Abeta-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS One 2012, 6:e29102.
19. Jang J.H., Surh Y.J. Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radic Biol Med 2003, 34:1100-1110.
20. Jeon B.T., Jeong E.A., Shin H.J., Lee Y., Lee D.H., Kim H.J., et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012, 61:1444-1454.
21. Jiang H., Wang Z., Wang Y., Xie K., Zhang Q., Luan Q., et al. Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action. Prog Neuropsychopharmacol Biol Psychiatry 2013, 47C:33-39.
22. Kang H., Welcher A.A., Shelton D., Schuman E.M. Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation. Neuron 1997, 19:653-664.
23. Lupien S.J., Maheu F., Tu M., Fiocco A., Schramek T.E. The effects of stress and stress hormones on human cognition: implications for the field of brain and cognition. Brain Cogn 2007, 65:209-237.
24. Marsden W.N. Synaptic plasticity in depression: molecular, cellular and functional correlates. Prog Neuropsychopharmacol Biol Psychiatry 2013, 43:168-184.
25. Mazzucchelli C., Brambilla R. Ras-related and MAPK signalling in neuronal plasticity and memory formation. Cell Mol Life Sci 2000, 57:604-611.
26. McEwen B.S. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005, 54:20-23.
27. McKittrick C.R., Magarinos A.M., Blanchard D.C., Blanchard R.J., McEwen B.S., Sakai R.R. Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites. Synapse 2000, 36:85-94.
28. Mebratu Y., Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer?. Cell Cycle 2009, 8:1168-1175.
29. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60.
30. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996, 16:2365-2372.
31. Orsu P., Murthy B.V., Akula A. Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats. J Neural Transm 2013, 120:1217-1223.
32. Qi X., Lin W., Wang D., Pan Y., Wang W., Sun M. A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behav Brain Res 2009, 199:203-209.
33. Radecki D.T., Brown L.M., Martinez J., Teyler T.J. BDNF protects against stress-induced impairments in spatial learning and memory and LTP. Hippocampus 2005, 15:246-253.
34. Roozendaal B. Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem 2002, 78:578-595.
35. Roux P.P., Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004, 68:320-344.
36. Sakamoto K., Karelina K., Obrietan K. CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem 2011, 116:1-9.
37. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985, 5:1222-1227.
38. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995, 15:1768-1777.
39. Sun A.Y., Chen Y.M., James-Kracke M., Wixom P., Cheng Y. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem Res 1997, 22:1187-1192.
40. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000, 20:4030-4036.
41. Tiwari V., Chopra K. Resveratrol abrogates alcohol-induced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain. Neurochem Int 2013, 62:861-869.
42. Uno H., Tarara R., Else J.G., Suleman M.A., Sapolsky R.M. Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 1989, 9:1705-1711.
43. Wang J., Ho L., Zhao Z., Seror I., Humala N., Dickstein D.L., et al. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J 2006, 20:2313-2320.
44. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997, 134:319-329.
45. World Health Organization International guiding principles for animal research. Chronicle 1985, 39:51.
46. Xu Y., Ku B., Tie L., Yao H., Jiang W., Ma X., et al. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res 2006, 1122:56-64.
47. Xu Y., Wang Z., You W., Zhang X., Li S., Barish P.A., et al. Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol 2010, 20:405-413.
48. Yau J.L., Noble J., Thomas S., Kerwin R., Morgan P.E., Lightman S., et al. The antidepressant desipramine requires the ABCB1 (Mdr1)-type p-glycoprotein to upregulate the glucocorticoid receptor in mice. Neuropsychopharmacology 2007, 32:2520-2529.
49. Yu Y., Wang R., Chen C., Du X., Ruan L., Sun J., et al. Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences. J Psychiatr Res 2013, 47:315-322.
50. Zhang F., Liu J., Shi J.S. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Euro J Pharmacol 2010, 636:1-7.
51. Zhuang H., Kim Y.S., Koehler R.C., Dore S. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann N Y Acad Sci 2003, 993:276-286. [discussion 87-8].